Principal Financial Group
ATOS icon

Principal Financial Group’s Atossa Therapeutics ATOS Stock Holding History

Principal Financial Group’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-683
Closed -$15.6K – 2213
2024
Q3 		$15.6K Sell
683
-197
-22% -$3.98K ﹤0.01% 2213
2024
Q2 		$15.7K Buy
+880
New +$19.5K ﹤0.01% 2350
2022
Q4 		– Sell
-976
Closed -$12K – 2450
2022
Q3 		$12K Buy
976
+29
+3% +$421 ﹤0.01% 2476
2022
Q2 		$15K Sell
947
-688
-42% -$10.8K ﹤0.01% 2500
2022
Q1 		$31K Sell
1,635
-115
-7% -$2.34K ﹤0.01% 2506
2021
Q4 		$42K Buy
1,750
+1,033
+144% +$37.8K ﹤0.01% 2489
2021
Q3 		$35K Sell
717
-207
-22% -$12K ﹤0.01% 2548
2021
Q2 		$88K Buy
+924
New +$48.9K ﹤0.01% 2545

Other funds holding ATOS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return